NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying its ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogues, into more effective and safer medicines.
Hugh Griffith
CEO
Ian Webster
CFO
thematic
Consumer
thematic
Energy & Resources